Insulin derivatives with increased zinc binding

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6221837
SERIAL NO

08900574

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Insulin derivatives with increased zinc binding ##STR1## where Z is a histidine residue or a peptide having 2 to 35 genetically encodable amino acid residues, having 1 to 5 histidine residues, are suitable for the production of pharmaceutical preparations for the treatment of diabetes. Insulins of the formula I form complexes with zinc.sup.++, comprising an insulin hexamer and approximately 5 to 9 mol of zinc.sup.++ per hexamer.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOECHST AKTIENGESELLSCHAFT65926 FRANKFURT AM MAIN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ertl, Johann Bremthal, DE 8 154
Geisen, Karl Frankfurt, DE 33 492
Habermann, Paul Eppstein, DE 46 702
Seipke, Gerhard Hofheim, DE 16 346

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 28 Citation Count
  • A61K Class
  • 81.75 % this patent is cited more than
  • 24 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges2541395474208105533417164102701 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0100200300400500600700800900100011001200130014001500

Forward Cite Landscape

Load Citation